TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Bank of Marin Bancorp (BMRC)

Financial Services Banks - Regional
29.30 $
+0.5% vs. previous close
Closing price · As of: 3. Aug 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Bank of Marin Bancorp.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 2 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
29.20$
Open
29.40$
Day High
29.80$
Day Low
29.20$
Volume
169,708shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
21.90 $ 30.30 $
08/07/2025 07/27/2026

Current price 29.30 $ — 88% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.5$B
Shares Outstanding
16Mio.
Float
93.8%
Beta
0.8

Performance

Perf. 1M
6.90%
Perf. 3M
10.10%
Perf. 6M
5.60%
YTD Performance (%)
3.50%
52-Week-High Distance
-7.6%
Perf. 1Y
37.17%
Perf. 3Y
56.74%
Perf. 5Y
2.42%
Perf. 10Y
63.26%
Perf. Since Inception
-99.86%

Technical Indicators

MA 38 Days
27.80$
MA 50 Days
27.30$
MA 200 Days
26.30$
RSI (14)
57.9
Volatility 30 Days
33.9%
Volatility 250 Days
27.6%

Calculated from the price history · as of 08/04/2026

Valuation

P/E
Forward P/E
11.8
PEG
2.6
P/B
1.3
P/S
2.5
EV/EBITDA
0.0
Price/FCF
14.1

Profitability

Gross Margin
100.0%
EBIT Margin
Net Margin
-23.6%
Return on Equity
-7.7%
Return on Assets
-0.4%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
0.1
Altman Z″
6.21
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
25.30%
EPS Growth Last Quarter
76.70%
Sales Growth (Year)
51.85%
Forward Sales Growth
6.54%
Forward EPS Growth
10.10%

Dividend

Dividend Yield
3.43%
Dividend Per Share (TTM)
1.00$
Payout Ratio
47.6%
Years Without a Cut
20Years
Increase Streak
0Years

Quality & Screener

Stage
2
RS Rating
48
EPS Rating
82
Piotroski
7 out of 9
Fundamental Rating
B (62 out of 100)
Altman Z″
6.21

AAQS

2/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 8.5%
  • Exp. sales growth 3Y > 5% -8.7%
  • EBIT growth 10Y > 5% 3.9%
  • Exp. EBIT growth 3Y > 5% -6.3%
  • Net debt < 4x EBIT -3.4x
  • EBIT positive, 10Y straight 9
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 13.6%
  • ROCE > 15% 1.3%
  • Expected return > 10% 1.1%

View all AAQS quality stocks · Read the methodology at AlleAktien

Source: fundamental data

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

7 of 10 Solid growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 7.9% failed
  • More than 10% revenue growth is expected for the coming year 6.5% failed
  • Share count grows by less than 3% a year -0.2% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 72.9% passed
  • Gross margin at 40% or higher and without meaningful erosion 76.1% passed
  • Goodwill from acquisitions does not grow faster than revenue 1.9% passed
  • Net debt below twice EBITDA 178 m net cash passed
  • Operating cash flow covers the profits of the last three years 48 m passed
  • Return on capital at 15% or higher, or up versus two years ago 1.3% failed
  • Insiders hold at least 10% or are net buyers 9.6% passed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Analysts & Price Target

Current Price 29.30 $
Price Target (average) 31.60 $

The price target sits 7.8% above the current price.

Consensus
Sell
Analyst Ratings
6
Distribution of Recommendations
Strong Buy 3
Buy 1
Hold 2
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 2.25 2.05 – 2.32 139 47.5% 6
12/31/2027 2.40 2.02 – 2.64 147 6.6% 6

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 38.4 $M Q4 2025: Q1 · 37.2 $M Q1 2025: Q2 · 19.6 $M Q2 2025: Q3 · 40.7 $M Q3 2025: Q4 · 79.3 $M Q4 2026: Q1 · 46.6 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.38 889.00 38 30.80 15.60 11 11
2025: Q1 0.30 67.80 37 3.10 13.10 5 5
2025: Q2 -0.53 20 435.70 -43.50 8 7
2025: Q3 0.47 66.00 41 6.20 18.50 13 12
2025: Q4 2.49 561.80 79 106.50 49.90 13 13
2026: Q1 0.53 74.80 47 25.40 18.30 1 1
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 85 36 23 1.89 25 231 2,023
2017 85 29 16 1.27 27 297 2,468
2018 105 43 33 2.33 42 316 2,521
2019 110 46 34 2.48 41 337 2,707
2020 108 41 30 2.22 41 358 2,912
2021 118 45 33 2.30 45 450 4,314
2022 141 64 47 2.92 55 412 4,147
2023 142 26 20 1.24 36 439 3,804
2024 116 -14 -8 -0.52 28 435 3,701
2025 177 52 43 2.73 39 395 3,905

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Bank of Marin Bancorp ist die Holdinggesellschaft der Bank of Marin, die kleinen und mittleren Unternehmen, gemeinnützigen Organisationen und Gewerbeimmobilieninvestoren in den USA eine Reihe von Finanzdienstleistungen anbietet. Das Unternehmen bietet Privat- und Geschäftsgirokonten und…

Employees315
HeadquartersNovato, CA
Address504 Redwood Blvd., 94947 Novato, United States
Phone415 763 4520
Websitebankofmarin.com
IPO Date23. Dec 1999
ISINUS0634251021
Stock Split2:1 on 11/28/2018

Management

Management
Name Title Birth Year
Timothy D. Myers President, CEO & Director 1971
David Bonaccorso Executive VP, CFO & Treasurer
Misako Stewart Executive VP & Chief Credit Officer of Bank of Marin 1969
David Bloom Executive VP & Head of Commercial Banking 1961
Susan Ramirez CPA First VP, Controller & Principal Accounting Officer 1981
Sathis Arasadi Executive VP & Chief Information Officer 1972
David A. Merck Senior VP and Director of Audit, Compliance & Risk 1963
Boo Wilson Chief Marketing Officer
Robert Gotelli Executive VP & Director of Human Resources 1965
Patrick J. London Executive VP & Director of Private Banking 1958

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
30. Jul 2026 Anderson Nicolas C Director Buy 175 28.88 5,054
15. May 2026 Myers Timothy D PRESIDENT & CEO Other 280 25.92 7,258
14. May 2026 Sathis Arasadi EXECUTIVE VICE PRESIDENT Other 31 0.00
14. May 2026 Stewart Misako EXECUTIVE VICE PRESIDENT Other 109 0.00
14. May 2026 Campbell Brandi EXECUTIVE VICE PRESIDENT Other 69 0.00
14. May 2026 Gotelli Robert EXECUTIVE VICE PRESIDENT Other 357 0.00
14. May 2026 Myers Timothy D PRESIDENT & CEO Other 314 0.00
13. Feb 2026 Myers Timothy D PRESIDENT & CEO Other 214 27.90 5,971
31. Dec 2025 Sathis Arasadi EXECUTIVE VICE PRESIDENT Other 42 0.00
31. Dec 2025 Sathis Arasadi EXECUTIVE VICE PRESIDENT Other 838 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?